The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- American Pharoah Has Final Breeze for Belmont
- F-T Kentucky July Sale Catalogs 332 Yearlings
- Keen Ice Breezes Half-Mile for Belmont
- Pan American Conference Draws a Crowd
- NBC Set for Belmont Stakes Coverage
- McLaughlin: Frosted Has to Have 'A-Plus' Day
- What's Going On Here: Embracing Change
- Fairmount Sale Hinges on Approval for Slots
- Bill Authorizes New Jersey Casino Referendum
- Trainer Michael de Kock on Mubtaahij